Linfedema penoescrotal secundario a hidrosadenitis supurativa: a propósito de un caso, revisión de las opciones quirúrgicas

Abstract

Lymphedema is the result of an alteration of the lymphatic drainage, and its most common worldwide cause is filariasis. In our practice usually is associated to neoplasic, inflammatory and granulomatous processes, radiotherapy, hydroelectrolytic disbalances, and idiopathic. It can affect any part of the body, including the penis and scrotum. The genital lymphedema is a rare presentation, it corresponds to 0.6% of lymphedema. However, causes serious functional, social and emotional limitations for the patient. Too often have pain, recurrent infections, sexual dysfunction, cosmetic deformity, sometimes it limits mobility and ambulation. Although there are several treatment options, both medical and surgical, it has not been found ideal for this disease. We present a 43 years old patient with penoscrotal lymphedema due to hidradenitis suppurativa, it limits his normal activity. The patient was referred to our center after unsuccessful medical treatment (doxycycline and clindamycin cycles). Surgical treatment consisted of total excision of the skin and subcutaneous tissue to Buck's fascia. Split thickness skin grafts were used to cover the defect. The result was satisfactory both functionally and aesthetically.

Unilateral Breast Skin Changes in Patient With Hidradenitis Suppurativa: Malignancy Versus Lymphedema

“…Medical management using adalimumab, infliximab, minocycline, and isotretinoin have also been reported with varying results [1,5,6]. Many providers also treat HS lymphedema with surgical management, which has been effective both functionally and aesthetically [1,7,8].…”

The role of biologic treatment in special scenarios in hidradenitis suppurativa: Facial and nape phenotype, dissecting cellulitis of the scalp, and lymphedema

“…Dissecting cellulitis of the scalp (DCS), facial HS, nape HS, and HS lymphedema are examples of atypical HS presentations. Its management is generally complex, showing variable response to therapies, with the need for biologic treatments in a high percentage of cases 3‐6 . The aim of this study is to identify those patients with atypical HS who have an inadequate response to first‐line antibiotics within a cohort of patients with HS, and to describe the efficacy of the biologic therapy and adjuvant therapeutic interventions used.…”